Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Loading...
Community
/
United States
/
Pharmaceuticals & Biotech
/
Amneal Pharmaceuticals
Create a narrative
Amneal Pharmaceuticals Community
NasdaqGS:AMRX Community
1
Narratives
written by author
0
Comments
on narratives written by author
14
Fair Values set
on narratives written by author
Community Investing Ideas
Amneal Pharmaceuticals
Popular
Undervalued
Overvalued
Amneal Pharmaceuticals
AN
AnalystConsensusTarget
Based on Analyst Price Targets
Global Health Trends And Pipeline Launches Will Fuel Future Potential
Key Takeaways Diversification into branded, complex products and biosimilars, along with global expansion and partnerships, positions the company for continued revenue and profit growth. Investments in manufacturing, supply chain optimization, and improved financial flexibility strengthen operational resilience and support margin improvement amid shifting healthcare dynamics.
View narrative
US$12.67
FV
23.0% undervalued
intrinsic discount
7.16%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
8
users have followed this narrative
11 days ago
author updated this narrative